Axsome Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Axsome Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Axsome Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 47.6M shares, a 8.94% increase year-over-year.
  • Axsome Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 45.4M shares, a 11.7% increase from 2022.
  • Axsome Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 40.7M shares, a 8.07% increase from 2021.
  • Axsome Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 37.6M shares, a 1.11% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 47.6M +3.9M +8.94% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 47.4M +3.87M +8.89% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 45.4M +4.77M +11.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 47.1M +5.41M +13% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 43.7M +4.59M +11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 43.5M +5.2M +13.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 40.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 41.7M +4.02M +10.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 39.1M +1.49M +3.95% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 38.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 37.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 37.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.